Literature DB >> 5126243

Intravenous gentamicin therapy for infections in patients with cancer.

G P Bodey, E Middleman, T Umsawasdi, V Rodriguez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5126243     DOI： 10.1093/infdis/124.supplement_1.s174

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin.

Authors:  H A Holt; J M Broughall; M McCarthy; D S Reeves
Journal:  Infection       Date:  1976       Impact factor: 3.553

2.  Gentamicin therapy of severe infections.

Authors:  C O Solberg; A Schreiner
Journal:  Infection       Date:  1973       Impact factor: 3.553

Review 3.  Aminoglycoside adaptive resistance: importance for effective dosage regimens.

Authors:  M L Barclay; E J Begg
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use.

Authors:  G L Daikos; V T Lolans; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

5.  Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.

Authors:  M L Barclay; E J Begg; S T Chambers
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.